Atomera Incorporated (ATOM)
NASDAQ: ATOM · Real-Time Price · USD
4.660
-0.340 (-6.80%)
At close: Aug 1, 2025, 4:00 PM
4.699
+0.039 (0.83%)
After-hours: Aug 1, 2025, 7:44 PM EDT
CTI BioPharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CTI BioPharma stock has a target of 7.00, which predicts a 50.21% increase from the current stock price of 4.66.
Price Target: $7.00 (+50.21%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 31, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for CTI BioPharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $13 → $7 | Strong Buy | Maintains | $13 → $7 | +50.21% | Jul 31, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $13 → $17 | Strong Buy | Maintains | $13 → $17 | +264.81% | Apr 27, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +500.86% | Jun 9, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 18, 2018 |
Financial Forecast
Revenue This Year
408.00K
from 135.00K
Increased by 202.22%
Revenue Next Year
5.41M
from 408.00K
Increased by 1,225.00%
EPS This Year
-0.57
from -0.68
EPS Next Year
-0.42
from -0.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 420,000 | 5.6M |
| Avg | 408,000 | 5.4M |
| Low | 392,000 | 5.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 211.1% | 1,264.0% |
| Avg | 202.2% | 1,225.0% |
| Low | 190.4% | 1,173.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.59 | -0.43 |
| Avg | -0.57 | -0.42 |
| Low | -0.55 | -0.40 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.